EU Revises RoHS Annex II for Phthalate Limits

On July 28, 2026, the Official Journal of the European Union published Regulation (EU) 2026/1342, amending RoHS Annex II and setting a clearer compliance timetable for phthalates in electrical and electronic equipment. From an industry perspective, the update deserves close attention because it affects not only product design, but also material selection, supplier documentation, and export readiness for sectors such as Smart Home, Mobile Accessories, CCTV Systems, and Medical Equipment shipping into the EU market.

What the amendment formally changes

According to the information provided, Regulation (EU) 2026/1342 was officially published in the OJEU on July 28, 2026 as a revision to Annex II of the RoHS Directive. The amendment will apply from February 1, 2027.

The confirmed substance-related change is that DEHP, BBP, and DBP in electrical and electronic equipment will be subject to a stricter limit of 100 ppm. The amendment also brings DIBP into scope for the first time.

The update is described as directly affecting compliance design and supply chain certification arrangements for electronic products exported to the EU, including Smart Home devices, Mobile Accessories, CCTV Systems, and Medical Equipment.

Where the immediate pressure is likely to appear

Export-facing product teams will need to reassess material compliance

Analysis shows that manufacturers and trading companies selling electrical and electronic equipment into the EU are the first group likely to feel the effect. The reason is straightforward: the amendment is tied to substance limits and product compliance, which means design, bill-of-material decisions, and internal approval processes may all need closer review before the February 2027 date.

What deserves closer attention is whether products in the named categories already rely on components or materials that may involve the listed phthalates. Even where final assembly remains unchanged, the compliance basis behind plastics, cables, coatings, or other material inputs may require renewed confirmation.

Procurement and supplier management will face a documentation burden

From an industry perspective, procurement teams and supply chain managers are likely to be affected through supplier qualification and certificate management. Because the amendment directly changes restricted substance expectations, purchasing decisions may no longer depend only on price, lead time, and performance, but also on whether upstream suppliers can support the revised RoHS Annex II requirements with adequate documentation.

The practical impact is likely to center on document collection, substance declarations, and consistency between supplier claims and export compliance files. This is especially relevant for businesses serving EU-bound orders across multiple product lines.

Testing, certification, and delivery coordination may become more time-sensitive

Analysis shows that service providers involved in compliance support, testing coordination, and shipment preparation may also see process changes. The amendment creates a defined future enforcement point, which can compress internal review cycles for companies that wait too long to verify materials and supporting records.

For customer-facing teams, the issue is not only technical conformity but also delivery confidence. Where EU clients request updated evidence before order confirmation or shipment, response speed and document completeness may become a commercial issue as much as a regulatory one.

What companies should watch now

Track the transition date against current order pipelines

What deserves closer attention is the gap between the publication date and the application date. The rule was published on July 28, 2026 and will apply from February 1, 2027. Companies exporting to the EU should compare that timeline with existing product launch schedules, customer commitments, and inventory planning, especially for affected electronic categories.

Review supplier declarations for all four named substances

Observably, the addition of DIBP changes the scope of what some companies may need to confirm upstream. Businesses should not treat this only as a tighter threshold issue for DEHP, BBP, and DBP; it also introduces a new controlled substance to supplier communication and recordkeeping workflows.

Separate legal text from operational readiness

From an industry perspective, publication of the amendment is a confirmed regulatory development, but operational readiness is a separate question. Companies should pay attention to whether their internal compliance files, supplier credentials, and customer-facing technical documents are aligned with the amended Annex II requirements before the application date arrives.

Focus on high-exposure product categories first

Based on the information provided, Smart Home, Mobile Accessories, CCTV Systems, and Medical Equipment are directly affected areas. For companies with broad portfolios, it is more practical to prioritize these categories first when checking material risks, document completeness, and export-related customer communication.

Why this reads as more than a routine update

Analysis shows that this development is best understood as a concrete regulatory signal rather than a speculative policy discussion. The legal act has been formally published, the substances are identified, and the application date is defined. That makes the issue immediately relevant for businesses with EU-facing electronic product lines.

At the same time, it is more appropriate to understand this as an active compliance transition rather than a fully settled business outcome. The amendment itself is confirmed, but how quickly different companies adapt across sourcing, certification, and customer communication will determine the operational impact.

How the market may need to interpret this update

The industry significance of this amendment lies in its direct link between substance control and export execution. It does not merely add another policy headline; it creates a practical checkpoint for product compliance, supplier verification, and certification arrangements tied to EU market access.

A neutral reading is that this is a near-term compliance change with longer-term signaling value. In the short term, affected companies need to focus on readiness for the February 2027 application date. In the longer term, the update suggests continued attention to substance control expectations in EU-bound electronics, which makes ongoing monitoring necessary rather than optional.

Basis of this article and points for continued verification

This article is based on the user-provided news title, event date, and event summary regarding the July 28, 2026 publication of Regulation (EU) 2026/1342 in the OJEU and its amendment to RoHS Annex II.

For this type of development, commonly relevant source categories include official government or regulatory notices, company compliance notices, industry association updates, authoritative media reporting, and standards-related documents. The specific official source link was not provided in the input, so the exact source document path still needs ongoing verification.

Further attention should remain on any subsequent official wording, implementation-related clarifications, and how affected companies translate the amendment into procurement, certification, and EU delivery workflows.